The Independent Institute

 
        

American Patients Can Access Far More New Cancer Drugs than Others Can »

New research by scholars at the University of Pittsburgh shows that American patients have significantly better access to new cancer medicines than their peers in other developed countries: Of 45 anticancer drug indications approved in the United States between January 1, 2009, and December 31, 2013, 64% (29) were approved by the European Medicines...
Read More »

Ten Percent of Cancer Drug Spending Is Wasted »

A remarkable study published in the BMJ concludes that $1.8 billion of the $18 billion spent on the 20 most expensive cancer drugs in the United States is wasted due to cunning marketing by drug-makers. Chemotherapeutic doses are often adjusted by body weight. However, the drugs are shipped in vials containing doses appropriate to...
Read More »

British National Health Service Stops Paying for Lifesaving Drugs »

Britain’s government-monopoly (single-payer) health plan, the National Health Service (NHS), has announced plans to stop paying for the most innovative, lifesaving drugs: More than 5,000 cancer patients will be denied life-extending drugs under plans which charities say are a “dreadful” step backwards for the NHS. Health officials have just announced sweeping restrictions on treatment,...
Read More »

  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org